Covidien

Covidien, formerly Tyco Healthcare, is one of the largest healthcare devices and supplies companies worldwide, headquarted in Pembroke Parish, Bermuda. On June 29, 2007, Tyco Healthcare became a a wholly independent publicly traded company named Covidien Ltd. nyse: COV

Structure
As a division of the larger conglomerate, Tyco Healthcare acquired numerous brands over the years including:
 * Sherwood, Davis & Geck sutures
 * Unites States Surgical / AutoSuture surgical intruments
 * Valleylab electrosurgery equipment
 * Syneture wound closure
 * Nellcor pulse oximetry
 * Puritan Bennett ventilators and respirators
 * Kendall patient care products
 * Uni-Patch electrotherapy
 * Mallinckrodt imaging
 * Mallinckrodt pharmaceuticals, including J. T. Baker
 * Tyco Retail group

Tyco Healthcare structured these acquisitions into multiple Divisions, under three major reporting units, as of 2004:


 * 1 Medical Devices & Supplies unit, with five primary divisions:
 * Medical Division - brands: Kerlix, Curity, Wings, SCD, T.E.D., Monojet Magellan, Kangaroo, Devon O.R., Medi-Trace
 * Surgical Division - brands: AutoSuture, Syneture, Valley Lab, Force FX, Ligasure, Cool-Tip RF
 * Respiratory Division - brands: Nellcor, Puritan Bennett, Oximax, Mallinckrodt, Shiley, Helios
 * Imaging Division - brands: Mallinckrodt Imaging, Optiray X-ray, Optimakr MRI, Technescan MAG3
 * International Division


 * 2 Pharmaceuticals unit
 * Mallinckrodt Pharmaceutical Division
 * Bulk Pharmaceuticals
 * Dosage Pharmaceuticals
 * Specialty Chemicals - brands: J.T. Baker


 * 3 Retail unit

Tyco Healthcare/Covidien's competitors include Johnson & Johnson, 3M and Bristol Myers Squibb.

History
Tyco Healthcare grew by acquisition to become one of the largest healthcare companies in the world. As a division, Tyco Healthcare annually generated about a quarter of the revenue of the overall parent conglomerate.

In 1995 Richard J. Meelia became President of the Tyco Healthcare division. Meelia continued in that position through at least 2004, and later became promoted into the newly formed position of CEO of Tyco Healthcare.

In 2002 Tyco Healthcare generated less than $8 billion in revenue.

In 2003 the division brought in over $8 billion in revenue.

In 2004 the division grew to over $9 billion in revenue with double digit earnings growth, and made up nearly a quarter of the overall Tyco International revenue.

In January 2007, Tyco filed with the SEC for permission to spin off its healthcare division into a separate, independent and publicly-traded company.

Covidien continues to operate in the surgical devices, medical imaging, medical supplies and pharmaceutical markets.